NCT01189747 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines | Biotech Hunter

Enrollment

446

Participants

Timeline

Start Date

October 1, 2010

Primary Completion Date

April 1, 2011

Study Completion Date

July 1, 2011

Conditions

Lateral Canthus RhytidesCrow's Feet Lines

Interventions

BIOLOGICAL

onabotulinumtoxinA

24 units onabotulinumtoxinA (botulinum toxin Type A) total dose injected into bilateral Crow's Feet Line areas on Day 1

DRUG

normal saline

Injected into bilateral Crow's Feet Line areas on Day 1

Trial Locations (4)

Newport Beach

Aalst

Vancouver

Sutton Coldfield